• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mdm2和p53在结直肠上皮性肿瘤中的表达。

Expression of mdm2 and p53 in epithelial neoplasms of the colorectum.

作者信息

Hao X P, Günther T, Roessner A, Price A B, Talbot I C

机构信息

Academic Department of Pathology, Northwick Park and St Mark's NHS Trust, Harrow, UK.

出版信息

Mol Pathol. 1998 Feb;51(1):26-9. doi: 10.1136/mp.51.1.26.

DOI:10.1136/mp.51.1.26
PMID:9624416
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC395604/
Abstract

AIMS

To evaluate the respective roles of mdm2 (murine double minute 2) and p53 in the development of colorectal carcinoma.

METHODS

Formalin fixed, paraffin wax embedded tissues from 72 sporadic adenomas and 55 carcinomas were investigated by means of immunohistochemistry for mdm2 and p53.

RESULTS

mdm2 was expressed weakly in 17 of 72 (23.6%) adenomas and in 14 of 55 (25.4%) carcinomas. p53 was expressed in 19 of 72 (26.4%) adenomas and in 23 of 55 (41.8%) carcinomas. Four adenomas and five carcinomas showed positive staining for both proteins. Overexpression of p53 in adenomas was associated with moderate and severe dysplasia but not with tumour size. No associations were found between the expression of mdm2 and either the degree of dysplasia or tumour size. In carcinomas, neither the expression of p53 nor mdm2 correlated with Dukes's stage, metastasis, or differentiation. No associations were found between the expression of p53 and mdm2 in either adenomas or carcinomas.

CONCLUSIONS

Although mdm2 has been reported to be an oncogene, it does not appear to play a major role in the development of colorectal carcinoma.

摘要

目的

评估mdm2(小鼠双微体2)和p53在结直肠癌发生发展中的各自作用。

方法

采用免疫组织化学方法对72例散发性腺瘤和55例癌组织的福尔马林固定、石蜡包埋组织进行mdm2和p53检测。

结果

mdm2在72例腺瘤中的17例(23.6%)和55例癌中的14例(25.4%)呈弱表达。p53在72例腺瘤中的19例(26.4%)和55例癌中的23例(41.8%)呈表达。4例腺瘤和5例癌两种蛋白均呈阳性染色。腺瘤中p53的过表达与中重度发育异常相关,但与肿瘤大小无关。mdm2的表达与发育异常程度或肿瘤大小均无相关性。在癌组织中,p53和mdm2的表达均与Dukes分期、转移或分化无关。腺瘤或癌组织中p53和mdm2的表达之间均无相关性。

结论

尽管mdm2已被报道为一种癌基因,但它似乎在结直肠癌的发生发展中不起主要作用。

相似文献

1
Expression of mdm2 and p53 in epithelial neoplasms of the colorectum.mdm2和p53在结直肠上皮性肿瘤中的表达。
Mol Pathol. 1998 Feb;51(1):26-9. doi: 10.1136/mp.51.1.26.
2
MDM2/p53 protein expression in the development of colorectal adenocarcinoma.MDM2/p53蛋白表达在结直肠癌发生发展中的作用
J Gastrointest Surg. 2000 Jan-Feb;4(1):109-14. doi: 10.1016/s1091-255x(00)80041-4.
3
Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum.结直肠癌腺瘤和癌中分期、分级、增殖以及p53和CD44表达之间的关系
J Clin Pathol. 1995 Dec;48(12):1098-101. doi: 10.1136/jcp.48.12.1098.
4
Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.大肠腺瘤和癌中的细胞凋亡及免疫组化bcl-2表达。癌变及预后意义方面
Cancer. 1996 Jan 15;77(2):255-64. doi: 10.1002/(SICI)1097-0142(19960115)77:2<255::AID-CNCR6>3.0.CO;2-L.
5
Expression of p53 and mdm2 mRNA and protein in colorectal carcinomas.p53和mdm2 mRNA及蛋白在结直肠癌中的表达
Eur J Cancer. 1999 Jul;35(7):1083-8. doi: 10.1016/s0959-8049(99)00058-1.
6
Expression of Bcl-2 and p53 in the colorectal adenoma-carcinoma sequence.Bcl-2和p53在结直肠腺瘤-癌序列中的表达。
Pathobiology. 1997;65(3):140-5. doi: 10.1159/000164115.
7
mdm2-p53 Interaction: lack of correlation with the response to 5-fluorouracil in advanced colorectal cancer.MDM2与p53的相互作用:与晚期结直肠癌对5-氟尿嘧啶的反应缺乏相关性。
Oncology. 2002;62(3):278-85. doi: 10.1159/000059576.
8
Immunohistochemical expression of p53, bcl-2, mdm2 and waf1/p21 proteins in colorectal adenocarcinomas.p53、bcl-2、mdm2和waf1/p21蛋白在结肠腺癌中的免疫组化表达
Anticancer Res. 1997 Jul-Aug;17(4A):2571-6.
9
P53-protein accumulation and MDM2-protein overexpression in gastric carcinomas. No apparent correlation with survival.胃癌中P53蛋白积累和MDM2蛋白过表达。与生存率无明显相关性。
Pathol Res Pract. 1999;195(12):815-20. doi: 10.1016/S0344-0338(99)80103-4.
10
Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenoma.结直肠癌和腺瘤微波固定石蜡包埋切片中p53表达的免疫组织化学研究
Am J Clin Pathol. 1992 Feb;97(2):244-9. doi: 10.1093/ajcp/97.2.244.

引用本文的文献

1
Association of Murine Double Minute 2 Genotypes and Lung Cancer Risk.鼠双微体 2 基因型与肺癌风险的关联。
In Vivo. 2020 May-Jun;34(3):1047-1052. doi: 10.21873/invivo.11874.
2
Contribution of Murine Double Minute 2 Genotypes to Colorectal Cancer Risk in Taiwan.小鼠双微体2基因分型对台湾地区结直肠癌风险的影响
Cancer Genomics Proteomics. 2018 Sep-Oct;15(5):405-411. doi: 10.21873/cgp.20099.
3
Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk.MDM2基因中SNP309多态性与结直肠癌风险之间关系的当前证据。
Tumour Biol. 2013 Dec;34(6):3721-9. doi: 10.1007/s13277-013-0956-z. Epub 2013 Aug 3.
4
MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option?MDM2 基因扩增和结肠癌中的蛋白表达:靶向 MDM2 是否是一种新的治疗选择?
Virchows Arch. 2011 Feb;458(2):197-203. doi: 10.1007/s00428-010-1012-7. Epub 2010 Nov 27.
5
Potential role of apoptosis and apoptotic regulatory proteins in colorectal neoplasia: correlations with clinico-pathological parameters and survival.细胞凋亡及凋亡调节蛋白在结直肠肿瘤形成中的潜在作用:与临床病理参数及生存率的相关性
Dig Dis Sci. 2008 Feb;53(2):451-60. doi: 10.1007/s10620-007-9857-6. Epub 2007 Jun 12.
6
MDM2 overexpression with alteration of the p53 protein and gene status in oral carcinogenesis.MDM2过表达与口腔癌发生过程中p53蛋白及基因状态的改变
Jpn J Cancer Res. 2000 May;91(5):492-8. doi: 10.1111/j.1349-7006.2000.tb00972.x.
7
MDM2/p53 protein expression in the development of colorectal adenocarcinoma.MDM2/p53蛋白表达在结直肠癌发生发展中的作用
J Gastrointest Surg. 2000 Jan-Feb;4(1):109-14. doi: 10.1016/s1091-255x(00)80041-4.

本文引用的文献

1
Regulation of p53 stability by Mdm2.Mdm2对p53稳定性的调控。
Nature. 1997 May 15;387(6630):299-303. doi: 10.1038/387299a0.
2
Mdm2 promotes the rapid degradation of p53.Mdm2促进p53的快速降解。
Nature. 1997 May 15;387(6630):296-9. doi: 10.1038/387296a0.
3
A molecular and immunohistochemical study of the MDM2 protein isoforms and p53 gene product in bronchogenic carcinoma.支气管源性癌中MDM2蛋白异构体和p53基因产物的分子及免疫组化研究
J Pathol. 1996 Oct;180(2):129-37. doi: 10.1002/(SICI)1096-9896(199610)180:2<129::AID-PATH646>3.0.CO;2-8.
4
Analysis of the proportion of p53 bound to mdm-2 in cells with defined growth characteristics.分析具有特定生长特征的细胞中与mdm-2结合的p53的比例。
Oncogene. 1996 Jun 6;12(11):2279-89.
5
mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein.MDM-2抑制p53肿瘤抑制蛋白的G1期阻滞和凋亡功能。
Mol Cell Biol. 1996 May;16(5):2445-52. doi: 10.1128/MCB.16.5.2445.
6
Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.在一部分无p53突变的人类恶性胶质瘤中,MDM2基因的扩增和过表达。
Cancer Res. 1993 Jun 15;53(12):2736-9.
7
MDM2 gene amplification in metastatic osteosarcoma.转移性骨肉瘤中的MDM2基因扩增
Cancer Res. 1993 Jan 1;53(1):16-8.
8
Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.成人软组织肉瘤中mdm2和p53基因的分子异常
Cancer Res. 1994 Feb 1;54(3):794-9.
9
p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix.p53基因突变和MDM2扩增在子宫颈原发性癌中并不常见。
Am J Pathol. 1993 Nov;143(5):1398-405.
10
The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin.MDM2癌基因在慢性淋巴细胞白血病和B细胞起源的低度淋巴瘤中过表达。
Blood. 1994 Nov 1;84(9):3158-65.